# A Study of the Effect of ASP1941 on Cardiac Repolarization in Healthy Subjects

> **NCT01232413** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 88 (actual)

## Conditions studied

- Healthy Subjects
- Cardiac Repolarization

## Interventions

- **DRUG:** Placebo
- **DRUG:** ASP1941
- **DRUG:** Moxifloxacin

## Key facts

- **NCT ID:** NCT01232413
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2011-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01232413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01232413, "A Study of the Effect of ASP1941 on Cardiac Repolarization in Healthy Subjects". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01232413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*